BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND CACNA1D, CCHL1A2, Cav1_3, CACNL1A2, CACN4, CACH3, ENSG00000157388, 776 AND Treatment
12 results:

  • 1. CT features based preoperative predictors of aggressive pathology for clinical T1 solid renal cell carcinoma and the development of nomogram model.
    Wang K; Dong L; Li S; Liu Y; Niu Y; Li G
    BMC Cancer; 2024 Jan; 24(1):148. PubMed ID: 38291357
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Cost-effectiveness of Trastuzumab Deruxtecan for HER2-low Advanced Breast Cancer in the United States.
    Peng Y; Wang L; Peng L; Liu Q; Yi L; Luo X; Li S; Qin S; Wan X; Tan C; Chen G
    Clin Ther; 2023 Oct; 45(10):965-972. PubMed ID: 37537015
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Factors affecting survival and prognosis in surgically treated patients with spinal metastases arising from renal cell carcinoma.
    Lei M; Miao J
    BMC Urol; 2023 Jul; 23(1):118. PubMed ID: 37443069
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Establishment of a mutation prediction model for evaluating the efficacy of immunotherapy in renal carcinoma].
    Qin CP; Song YX; Ding MT; Wang F; Lin JX; Yang WB; DU YQ; Li Q; Liu SJ; Xu T
    Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Aug; 54(4):663-668. PubMed ID: 35950389
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. CT-based multi-phase Radiomic models for differentiating clear cell renal cell carcinoma.
    Chen M; Yin F; Yu Y; Zhang H; Wen G
    Cancer Imaging; 2021 Jun; 21(1):42. PubMed ID: 34162442
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Cancer Stage, treatment, and Survival Among Transgender Patients in the United States.
    Jackson SS; Han X; Mao Z; Nogueira L; Suneja G; Jemal A; Shiels MS
    J Natl Cancer Inst; 2021 Sep; 113(9):1221-1227. PubMed ID: 33704460
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Influence of gene expression on survival of clear cell renal cell carcinoma.
    Berglund A; Amankwah EK; Kim YC; Spiess PE; Sexton WJ; Manley B; Park HY; Wang L; Chahoud J; Chakrabarti R; Yeo CD; Luu HN; Pietro GD; Parker A; Park JY
    Cancer Med; 2020 Nov; 9(22):8662-8675. PubMed ID: 32986937
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The Diagnostic Yield and Concordance of Ureterorenoscopic Biopsies for Grading of Upper Tract Urothelial Carcinoma: A Dutch Nationwide Analysis.
    Freund JE; Duivenvoorden MJC; Sikma BT; Vernooij RWM; Savci-Heijink CD; Legemate JD; de Reijke TM
    J Endourol; 2020 Sep; 34(9):907-913. PubMed ID: 32483982
    [No Abstract]    [Full Text] [Related]  

  • 9. Cost-effectiveness of Management Options for Small Renal Mass: A Systematic Review.
    Wang Y; Chen YW; Leow JJ; Levy AC; Chang SL; Gelpi FH
    Am J Clin Oncol; 2016 Oct; 39(5):484-90. PubMed ID: 27322701
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Minimally invasive nephrectomy for Wilms tumors in children - data from SIOP 2001.
    Warmann SW; Godzinski J; van Tinteren H; Heij H; Powis M; Sandstedt B; Graf N; Fuchs J;
    J Pediatr Surg; 2014 Nov; 49(11):1544-8. PubMed ID: 25475791
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Clinical utility of the Glasgow Prognostic Score in patients undergoing curative nephrectomy for renal clear cell cancer: basis of new prognostic scoring systems.
    Lamb GW; Aitchison M; Ramsey S; Housley SL; McMillan DC
    Br J Cancer; 2012 Jan; 106(2):279-83. PubMed ID: 22166802
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Comparison of radiographical imaging modalities for measuring the diameter of renal masses: is there a sizeable difference?
    Mucksavage P; Kutikov A; Magerfleisch L; Van Arsdalen K; Wein AJ; Ramchandani P; Malkowicz SB
    BJU Int; 2011 Oct; 108(8 Pt 2):E232-6. PubMed ID: 21348913
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.